Cancer Specialty
Conference Coverage
- ASCO
- AACR 2024
- ASCO GI 2024
- ASH 2023
- SABCS 2023
- MOASC
- ASCO 2023

Advertisement

X (Twitter) LinkedIn Facebook

X (Twitter) LinkedIn Facebook

Cancer Specialty
Conference Coverage
- ASCO
- AACR 2024
- ASCO GI 2024
- ASH 2023
- SABCS 2023
- MOASC
- ASCO 2023

Home » Sigrun Hallmeyer, MD @ACCCBuzz #immunotherapy Immuno-Oncology and What Lies Ahead

Immunotherapy

Sigrun Hallmeyer, MD @ACCCBuzz #immunotherapy Immuno-Oncology and What Lies Ahead

By EditorSeptember 20, 2020No Comments1 Min Read

Twitter LinkedIn Facebook Email

Share

Twitter LinkedIn Facebook Email

Sigrun Hallmeyer, MD at ACCC discusses Immuno-Oncology and What Lies Ahead

Follow on X (Twitter) Follow on LinkedIn Follow on Facebook Follow on Google News

Share. Twitter LinkedIn Facebook Email

Related Posts

ASCO 2024 Top 5 Presentations to See from Omid Hamid, MD

Immunotherapy 1 Min Read

Cell Therapy for Solid Tumors: Immunotherapy Biomarkers Anusha Kalbasi, MD MOASC [2023]

Immunotherapy 2 Mins Read

Targeting Tumor Microenvironment Bridget Keenan, MD MOASC [2023]

Immunotherapy 2 Mins Read

Advertisement Sidebar

Recent Posts

BRCA Carriers Slicing Breast Cancer Odds: Does Surgery Lead to Longevity Leaps?
Palbociclib (IBRANCE) Revs Up Metastatic Breast Cancer in PATINA Results
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
Metastatic Breast Cancer: Trastuzumab (Herceptin) Factors for Long-Term Remission in HER2 negative
Breast Cancer New Nemeses: CDK4/6 Inhibitors Rave Against Recurrence, But Have They Crashed the EBC Party in NATALEE & monarchE’s Real-World Dance-Off?

Connect With Us on Social

Facebook
Twitter
LinkedIn

X (Twitter) LinkedIn Facebook

© 2025 Copyright Protected Medicus Networks, Inc..

Type above and press Enter to search. Press Esc to cancel.